Pharma-Bio Serv, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Pharma-Bio Serv, Inc. reported Cash And Cash Equivalents At Carrying Value of $14.46 million for the year ending 2022.

  • Pharma-Bio Serv, Inc. showed a decrease of -17.2% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from Pharma-Bio Serv, Inc.'s annual report (Form 10-K), filed with the SEC on January 30, 2023.
  • XBRL data for this metric is available from 2009 to 2022 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2009 to 2022), Pharma-Bio Serv, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 604.9%.
  • Historical annual values: Fiscal year 2022: $14.46 million | Fiscal year 2021: $17.47 million | Fiscal year 2020: $17.14 million | Fiscal year 2019: $15.49 million | Fiscal year 2018: $16.03 million | Fiscal year 2017: $11.59 million | Fiscal year 2016: $13.77 million | Fiscal year 2015: $14.89 million | Fiscal year 2014: $15.09 million | Fiscal year 2013: $12.05 million | Fiscal year 2012: $6.54 million | Fiscal year 2011: $4.32 million | Fiscal year 2010: $2.32 million | Fiscal year 2009: $2.05 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: